EFNA1 and neoplasm: Two years later, the same study group published their second article on the targeted delivery of highly stable, low-cytotoxicity let-7a microRNA-encapsulated ephrin-A1-conjugated liposomal nanoparticles in LC, which resulted in repressed Ras expression, as well as reduced NSCLC proliferation, migration, and tumor growth [76].